- Home
- RVPH vs CRIS Comparison
RVPH vs CRIS Comparison
Compare RVPH & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- CRIS
- Stock Information
- Founded
- RVPH 2006
- CRIS 2000
- Country
- RVPH United States
- CRIS United States
- Employees
- RVPH N/A
- CRIS N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RVPH Health Care
- CRIS Health Care
- Exchange
- RVPH Nasdaq
- CRIS Nasdaq
- Market Cap
- RVPH 33.4M
- CRIS 31.2M
- IPO Year
- RVPH N/A
- CRIS 2000
- Fundamental
- Price
- RVPH $1.15
- CRIS $4.09
- Analyst Decision
- RVPH Strong Buy
- CRIS Strong Buy
- Analyst Count
- RVPH 4
- CRIS 3
- Target Price
- RVPH $15.33
- CRIS $23.00
- AVG Volume (30 Days)
- RVPH 707.7K
- CRIS 84.3K
- Earning Date
- RVPH 11-14-2024
- CRIS 11-14-2024
- Dividend Yield
- RVPH N/A
- CRIS N/A
- EPS Growth
- RVPH N/A
- CRIS N/A
- EPS
- RVPH N/A
- CRIS N/A
- Revenue
- RVPH N/A
- CRIS $10,259,000.00
- Revenue This Year
- RVPH N/A
- CRIS N/A
- Revenue Next Year
- RVPH N/A
- CRIS N/A
- P/E Ratio
- RVPH N/A
- CRIS N/A
- Revenue Growth
- RVPH N/A
- CRIS 0.44
- 52 Week Low
- RVPH $0.60
- CRIS $3.51
- 52 Week High
- RVPH $5.67
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- RVPH 50.02
- CRIS 46.98
- Support Level
- RVPH $1.09
- CRIS $4.20
- Resistance Level
- RVPH $1.28
- CRIS $4.70
- Average True Range (ATR)
- RVPH 0.14
- CRIS 0.38
- MACD
- RVPH 0.01
- CRIS 0.08
- Stochastic Oscillator
- RVPH 34.88
- CRIS 60.50
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.